Pro-Dex, Inc. (NASDAQ:PDEX - Get Free Report)'s share price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $53.65 and traded as high as $67.76. Pro-Dex shares last traded at $66.72, with a volume of 97,231 shares trading hands.

Analyst Ratings Changes

Several analysts recently weighed in on PDEX shares. Ascendiant Capital Markets lifted their price target on shares of Pro-Dex from $56.00 to $70.00 and gave the company a "buy" rating in a report on Tuesday, May 12th. Zacks Research upgraded shares of Pro-Dex to a "hold" rating in a report on Tuesday, May 19th. Weiss Ratings raised shares of Pro-Dex from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Thursday, August 6th. Finally, Wall Street Zen raised shares of Pro-Dex from a "hold" rating to a "buy" rating in a research note on Saturday, June 13th. Two research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $70.00.

Read Our Latest Stock Analysis on PDEX

Pro-Dex Trading Up 0.7%

The stock's fifty day moving average price is $61.39 and its 200 day moving average price is $53.65. The stock has a market cap of $212.84 million, a P/E ratio of 18.43 and a beta of 0.02. The company has a current ratio of 3.67, a quick ratio of 2.14 and a debt-to-equity ratio of 0.32.

Insider Buying and Selling

In other Pro-Dex news, CEO Kirk Richard Lee Van, Jr. sold 4,128 shares of the company's stock in a transaction dated Friday, May 22nd. The shares were sold at an average price of $62.36, for a total value of $257,422.08. Following the sale, the chief executive officer owned 89,707 shares in the company, valued at approximately $5,594,128.52. This represents a 4.40% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 45.90% of the stock is owned by insiders.

Institutional Trading of Pro-Dex

A number of hedge funds have recently made changes to their positions in PDEX. Los Angeles Capital Management LLC purchased a new stake in shares of Pro-Dex in the 4th quarter worth approximately $37,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in Pro-Dex in the second quarter worth $50,000. Bank of America Corp DE boosted its holdings in Pro-Dex by 173.3% in the second quarter. Bank of America Corp DE now owns 1,692 shares of the medical instruments supplier's stock worth $74,000 after acquiring an additional 1,073 shares in the last quarter. Wells Fargo & Company MN grew its stake in shares of Pro-Dex by 65.4% in the fourth quarter. Wells Fargo & Company MN now owns 2,314 shares of the medical instruments supplier's stock worth $89,000 after acquiring an additional 915 shares during the last quarter. Finally, New York State Common Retirement Fund purchased a new stake in shares of Pro-Dex in the second quarter worth $105,000. 15.28% of the stock is owned by institutional investors.

Pro-Dex Company Profile

(Get Free Report)

Pro-Dex, Inc is a designer and manufacturer of precision drive systems and fluid management products serving the dental, medical, industrial and energy markets. The company specializes in high-speed, brushless micromotors and controllers, as well as pneumatic and fluid control devices, providing both standard and custom-engineered solutions for original equipment manufacturers.

Its product portfolio includes high-speed dental handpieces, turbine systems, rotary and reciprocating micro-drives, along with integrated fluid delivery systems.

Featured Stories

• Five stocks we like better than Pro-Dex
• Atlassian Just Pulled Off the Software Comeback Wall Street Wanted
• AST SpaceMobile Earnings Just Reminded Investors How Risky Space Can Be
• NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
• Apple’s Next iPhone Could Test How Much Pricing Power Is Left

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Pro-Dex Right Now?

Before you consider Pro-Dex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pro-Dex wasn't on the list.

While Pro-Dex currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here